Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A17255 | 27889327 | Mol Aspects Med | Epigenetics in non-alcoholic fatty liver disease. | 2016 | Details |
| A17256 | 27889186 | Cancer Cell | Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis. | 2016 | Details |
| A17257 | 27888103 | Biochem Biophys Res Commun | Luteolin improves non-alcoholic fatty liver disease in db/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c. | 2016 | Details |
| A17258 | 27887608 | Lipids Health Dis | Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study. | 2016 | Details |
| A17259 | 27885258 | Sci Rep | Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects. | 2016 | Details |
| A17260 | 27884920 | Gut | Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity. | 2016 | Details |
| A17261 | 27881858 | Int J Obes (Lond) | Safety and efficacy of bariatric surgery in patients with advanced fibrosis. | 2016 | Details |
| A17262 | 27881164 | BMC Endocr Disord | Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report. | 2016 | Details |
| A17264 | 27880981 | Hepatology | A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice. | 2017 | Details |
| A17265 | 27880977 | Hepatology | Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. | 2017 | Details |
| A17266 | 27879963 | Minerva Endocrinol | Hypogonadism and non-alcoholic fatty liver disease. | 2016 | Details |
| A17267 | 27879962 | Minerva Endocrinol | Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease. | 2016 | Details |
| A17268 | 27876107 | Br J Nutr | Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation. | 2016 | Details |
| A17269 | 27876064 | Lipids Health Dis | Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice. | 2016 | Details |
| A17270 | 27875636 | Liver Transpl | Evaluation of coronary artery disease in potential liver transplant recipients. | 2017 | Details |
| A17271 | 27874078 | Sci Rep | Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice. | 2016 | Details |
| A17272 | 27872651 | Evid Based Complement Alternat Med | A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17273 | 27872642 | Int J Endocrinol | Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients without Overt Diabetes Evaluated by 1H-Magnetic Resonance Spectroscopy. | 2016 | Details |
| A17274 | 27869531 | Metab Syndr Relat Disord | Associations Between Lifestyle Characteristics and the Presence of Nonalcoholic Fatty Liver Disease: A Case-Control Study. | 2016 | Details |
| A17275 | 27869416 | Arch Argent Pediatr | Non-alcoholic fatty liver disease: a new epidemic in children. | 2016 | Details |
| A17276 | 27869139 | Sci Rep | The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation. | 2016 | Details |
| A17277 | 27867167 | Nihon Hoshasen Gijutsu Gakkai Zasshi | Evaluation of Fat Quantification in the Liver Using Dual Energy CT. | 2016 | Details |
| A17278 | 27866836 | Cell Metab | Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP. | 2016 | Details |
| A17279 | 27866076 | J Nutr Biochem | Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model. | 2016 | Details |
| A17281 | 27863448 | Hepatology | Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. | 2017 | Details |
| A17282 | 27863346 | J Nutr Biochem | A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis. | 2016 | Details |
| A17283 | 27863204 | Appl Physiol Nutr Metab | TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions. | 2016 | Details |
| A17284 | 27863097 | Obesity (Silver Spring) | Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease. | 2016 | Details |
| A17285 | 27862937 | Luminescence | A rapid and high-throughput method for the determination of serum uric acid based on microarray technology and nanomaterial. | 2016 | Details |
| A17286 | 27862769 | Cancer Sci | NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis. | 2017 | Details |
| A17287 | 27862719 | Hepatol Res | Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression. | 2016 | Details |
| A17288 | 27862590 | J Magn Reson Imaging | Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? | 2016 | Details |
| A17290 | 27862096 | Aliment Pharmacol Ther | Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. | 2016 | Details |
| A17291 | 27861366 | Medicine (Baltimore) | Increased risk of nonalcoholic fatty liver disease with occupational stress in Chinese policemen: A 4-year cohort study. | 2016 | Details |
| A17293 | 27860427 | J Dig Dis | The role of ADIPOQ methylation in curcumin-administrated experimental nonalcoholic fatty liver disease. | 2016 | Details |
| A17294 | 27860077 | Pathol Int | Critical in vivo roles of histamine and histamine receptor signaling in animal models of metabolic syndrome. | 2016 | Details |
| A17295 | 27859643 | Congenit Anom (Kyoto) | Undernourishment in utero and hepatic steatosis in later life: A potential issue in Japanese people. | 2017 | Details |
| A17296 | 27859583 | J Gastroenterol Hepatol | External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients. | 2017 | Details |
| A17297 | 27859493 | Clin Exp Pharmacol Physiol | Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis. | 2017 | Details |
| A17298 | 27859470 | Aliment Pharmacol Ther | Non-alcoholic fatty liver diseases and risk of colorectal neoplasia. | 2016 | Details |
| A17300 | 27858497 | Epigenetics | High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liver. | 2016 | Details |
| A17302 | 27856635 | J Biol Chem | MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease: A NOVEL MOUSE MODEL OF OBESITY PARADOX. | 2016 | Details |
| A17303 | 27856445 | Am J Epidemiol | Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis. | 2016 | Details |
| A17307 | 27855657 | BMC Genet | Genetic dissection of the fatty liver QTL Fl1sa by using congenic mice and identification of candidate genes in the liver and epididymal fat. | 2016 | Details |
| A17308 | 27855393 | Ann Nutr Metab | Central Obesity and Liver Iron Content: A Noninvasive Assessment in General Population by Magnetic Resonance Imaging. | 2016 | Details |
| A17309 | 27855316 | J Nutr Biochem | A high-fat diet temporarily renders Sod1-deficient mice resistant to an oxidative insult. | 2016 | Details |
| A17310 | 27855315 | J Nutr Biochem | Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice. | 2016 | Details |
| A17311 | 27853276 | Sci Rep | SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease. | 2016 | Details |
| A17312 | 27853271 | Sci Rep | Foetal programming by methyl donor deficiency produces steato-hepatitis in rats exposed to high fat diet. | 2016 | Details |
| A17313 | 27853246 | Sci Rep | Plasma selenium levels and nonalcoholic fatty liver disease in Chinese adults: a cross-sectional analysis. | 2016 | Details |
| A17314 | 27852946 | Postgrad Med J | Non-alcoholic fatty liver disease and colorectal cancer. | 2016 | Details |
| A17315 | 27852719 | BMJ Open | Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population. | 2016 | Details |
| A17316 | 27852305 | Lipids Health Dis | Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice. | 2016 | Details |
| A17317 | 27851965 | Cell Rep | Adipose Snail1 Regulates Lipolysis and Lipid Partitioning by Suppressing Adipose Triacylglycerol Lipase Expression. | 2016 | Details |
| A17318 | 27851786 | PLoS One | Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles. | 2016 | Details |
| A17320 | 27848888 | Curr Drug Metab | Immunotherapy in Liver Diseases: A Balance Between Immunity and Tolerance. | 2016 | Details |
| A17321 | 27847552 | Oxid Med Cell Longev | Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17322 | 27846831 | BMC Pediatr | Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet. | 2016 | Details |
| A17323 | 27845424 | Sci Rep | MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. | 2016 | Details |
| A17324 | 27845265 | J Ethnopharmacol | The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells. | 2016 | Details |
| A17325 | 27844016 | Mol Biol Res Commun | Omentin-1 rs2274907 and resistin rs1862513 polymorphisms influence genetic susceptibility to nonalcoholic fatty liver disease. | 2016 | Details |
| A17326 | 27843095 | EBioMedicine | Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy. | 2016 | Details |
| A17328 | 27838603 | Hormones (Athens) | Postprandial dysmetabolism: Too early or too late? | 2016 | Details |
| A17330 | 27837780 | Gastroenterol Clin North Am | Pharmacotherapy in Treatment of Obesity. | 2016 | Details |
| A17331 | 27837778 | Gastroenterol Clin North Am | Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. | 2016 | Details |
| A17332 | 31435207 | J Taibah Univ Med Sci | The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus. | 2016 | Details |
| A17333 | 27837387 | Obes Surg | Vitamin D3 Loading Is Superior to Conventional Supplementation After Weight Loss Surgery in Vitamin D-Deficient Morbidly Obese Patients: a Double-Blind Randomized Placebo-Controlled Trial. | 2017 | Details |
| A17334 | 27836992 | J Lipid Res | Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study. | 2016 | Details |
| A17335 | 27836788 | Chem Biol Interact | Regression of fibrosis/cirrhosis by Glycine propionyl-l-carnitine treatment in d-Galactosamine induced chronic liver damage. | 2016 | Details |
| A17336 | 27836672 | Biochem Pharmacol | Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis. | 2016 | Details |
| A17338 | 27835657 | PLoS One | Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males. | 2016 | Details |
| A17339 | 27834919 | Int J Mol Sci | Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17340 | 27834813 | Biology (Basel) | The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17341 | 27834478 | Minerva Endocrinol | Iron overload and non-alcoholic fatty liver disease. | 2016 | Details |
| A17343 | 27833386 | World J Gastroenterol | Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry. | 2016 | Details |
| A17344 | 27833378 | World J Gastroenterol | Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. | 2016 | Details |
| A17345 | 27833139 | Sci Rep | Contributions of Streptococcus mutans Cnm and PA antigens to aggravation of non-alcoholic steatohepatitis in mice. | 2016 | Details |
| A17346 | 27832630 | Cell Physiol Biochem | Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity. | 2016 | Details |
| A17347 | 27832040 | Eur J Gastroenterol Hepatol | Short article: A randomized-controlled study of sitagliptin for treating diabetes mellitus complicated by nonalcoholic fatty liver disease. | 2017 | Details |
| A17348 | 27831642 | Eur Rev Med Pharmacol Sci | Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease. | 2016 | Details |
| A17349 | 27831641 | Eur Rev Med Pharmacol Sci | Metabolic syndrome is a risk factor for nonalcoholic fatty liver disease: evidence from a confirmatory factor analysis and structural equation modeling. | 2016 | Details |
| A17350 | 27831566 | Cell Death Dis | Cysteine cathepsins control hepatic NF-κB-dependent inflammation via sirtuin-1 regulation. | 2016 | Details |
| A17351 | 27830836 | Sci Rep | Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. | 2016 | Details |
| A17352 | 27828718 | J Med Food | 5,7-Dimethoxyflavone Attenuates Obesity by Inhibiting Adipogenesis in 3T3-L1 Adipocytes and High-Fat Diet-Induced Obese C57BL/6J Mice. | 2016 | Details |
| A17353 | 27827899 | Nutrients | Relationship between Added Sugars Consumption and Chronic Disease Risk Factors: Current Understanding. | 2016 | Details |
| A17354 | 27826704 | Hepatol Int | Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease. | 2016 | Details |
| A17358 | 27825671 | Eur J Intern Med | Nonalcoholic fatty liver and the severity of acute pancreatitis. | 2016 | Details |
| A17359 | 27824642 | Eur J Gastroenterol Hepatol | Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
| A17360 | 27824430 | Drug Res (Stuttg) | Dietary Fructose-Induced Hepatic Injury in Male and Female Rats: Influence of Resveratrol. | 2016 | Details |
| A17361 | 27824421 | Dtsch Med Wochenschr | [Elevated liver enzymes]. | 2016 | Details |
| A17362 | 27824080 | Sci Rep | Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1 expression and deacetylase activity. | 2016 | Details |
| A17364 | 27823604 | Endocrinol Metab Clin North Am | Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus. | 2016 | Details |
| A17365 | 27822971 | Expert Opin Drug Metab Toxicol | Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? | 2016 | Details |
| A17366 | 27822933 | J Korean Med Sci | Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases. | 2016 | Details |
| A17367 | 27822768 | Obes Surg | Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children. | 2017 | Details |
| A17368 | 27822476 | Biomed Res Int | Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells. | 2016 | Details |
| A17370 | 27822266 | Hepat Mon | Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study. | 2016 | Details |
| A17372 | 27821715 | Physiol Rep | A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis. | 2016 | Details |
| A17373 | 27821024 | Acta Gastroenterol Belg | Predictive value of neutrophiltolymphocyte ratio in the severity of non-alcoholic fatty liver disease among type 2 diabetes patients. | 2017 | Details |
| A17374 | 27818933 | Mol Metab | Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. | 2016 | Details |